Fig. 2: Plasma pTau181 and pTau217 levels across clinical diagnoses.
From: Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort
In each graph, boxplots show median, 25th percentile, 75th percentile, and range. Plasma pTau181 and pTau217 levels are shown across clinical diagnoses (N = 145; a, c) and stratified by cognitive and CSF biomarker status (N = 52; b, d). (Kruskal-Wallis test followed by Dunn’s multiple comparisons test; significant p-values are shown).
